Healixa(OTC) EMOR

Current Price$0.04

Market Cap$28.48M

Since IPO (2019)-94%

5 Year-95%

1 Year+196%

1 Month+2%

Healixa last closing stock price
Metric	Price	Date
Last close	USD 0.04	2026-07-22

Healixa stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-19.74%	USD 0.05	2026-07-10
1 month	+1.52%	USD 0.04	2026-06-22
3 month	+33.33%	USD 0.03	2026-04-22
Year to date	+300%	USD 0.01	2025-12-30
1 year	+195.75%	USD 0.01	2025-07-21
3 year	-84%	USD 0.25	2023-07-21
5 year	-95.12%	USD 0.82	2021-07-23
Since inception	-94.37%	USD 0.71	2019-04-15

Healixa Financials at a Glance

Market Cap

$28.48M

Revenue (TTM)

$575.00K

Net Income (TTM)

-$770.32K

EPS (TTM)

-$0.00

P/E Ratio

-50.00

Dividend

$0.00

Beta (Volatility)

-0.16 (Low)

Dividend

$0.00

Beta (Volatility)

-0.16 (Low)

Price

$0.04

Volume

600

Open

$0.04

Price

$0.04

Volume

600

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.01 - $0.07

Estimated Earnings Date

Sep 26, 2024

Dividend

$0.00

Beta (Volatility)

-0.16 (Low)

Price

$0.04

Volume

600

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.01 - $0.07

Estimated Earnings Date

Sep 26, 2024

EMOR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Healixa

Healixa Inc. is a technology company specializing in healthtech and fintech solutions. The company provides innovative tech solutions to enterprise partners across various industries, including employer benefits, travel, pharma, and logistics. Healixa also operates a digital pharmacy marketplace, enhancing its service offerings.

Products and Services

Tech solutions for healthtech and fintech sectors
Digital pharmacy marketplace for streamlined access to medications
Enterprise solutions tailored for diverse industries

Growth Outlook

Recent quarterly revenue reached $388,983, indicating potential for growth
Gross profit margin of 69% in Q1 suggests strong operational efficiency
Continued expansion into new markets expected to drive future revenue

Financial Highlights

Market capitalization stands at approximately $46 million
Trailing twelve months (TTM) revenue of $1.4 million reflects growth potential
Operating expenses for Q1 were $241,680, indicating investment in growth

Healixa Inc. operates at the intersection of technology and healthcare, providing essential services that cater to a wide range of industries. The company's focus on innovative solutions positions it well for future growth, particularly as it expands its digital pharmacy marketplace. Recent financial data indicates a positive trajectory, with significant revenue potential and a strong gross profit margin. The operational investments made in the first quarter suggest a commitment to scaling the business and enhancing service offerings. As Healixa continues to navigate the evolving landscape of healthtech and fintech, it remains poised for further development and market penetration.

AI Generated • Jul 8, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

CEO

Ian Parker

Website

healixa.com

Headquarters

Holbrook, NY 11741, US

EMOR Financials

Key Financial Metrics (TTM)

Gross Margin

77.38%

Operating Margin

-65.08%

Net Income Margin

-130.10%

Return on Equity

6.55%

Return on Capital

N/A

Return on Assets

-895.58%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.48M

Shares Outstanding

712.12M

Volume

600

Avg. Volume

15.75K

Financials (TTM)

Gross Profit

$385.47K

Operating Income

-$456.13K

EBITDA

-$445.09K

Operating Cash Flow

-$320.09K

Capital Expenditure

$3.00

Free Cash Flow

-$320.09K

Cash & ST Invst.

$0.00

Total Debt

$6.69M

Healixa Performance Analysis

Healixa annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-03-31	USD 15,092	N/A
2024	2024-03-31	USD 603,681	3900.0%
2025	2025-03-31	USD 702,908	16.4%
2026	2026-03-31	USD -94,442	N/A

Healixa sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2024-12-31	-76.4%
Q4	2025-03-31	2.6%
Q1	2025-06-30	313.0%
Q3	2025-12-31	N/A

Healixa annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-03-31	USD -0.01	180.0%
2024	2024-03-31	USD -0.01	-12.2%
2025	2025-03-31	USD -0.00	-88.4%
2026	2026-03-31	USD -0.00	-30.0%

Healixa sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2024-12-31	-100.0%
Q4	2025-03-31	-100.0%
Q1	2025-06-30	75.0%
Q3	2025-12-31	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$28.48M

N/A

Market Cap/Employee

$1.10M

N/A

Employees

N/A

Net Income

-$225.08K

-339.4%

EBITDA

-$159.40K

-640.0%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$0.00

-100.0%

Total Debt

$6.69M

+1.6%

Accounts Receivable

$28.00K

-90.6%

Inventory

$21.71K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$6.69M

+1.6%

Return on Assets

-8.96%

N/A

Return on Invested Capital

3.23%

N/A

Free Cash Flow

-$151.79K

+19.4%

Operating Cash Flow

-$151.79K

+19.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PBSVPharma-Bio Serv, Inc.

PBSVPharma-Bio Serv, Inc.$0.58+16.00%

ALRTFALR Technologies Inc.

ALRTFALR Technologies Inc.$0.02+20.17%

SPLTFSpotLite360 IOT Solutions, Inc.

SPLTFSpotLite360 IOT Solutions, Inc.$0.08+0.00%

VYNDVynleads, Inc.

VYNDVynleads, Inc.$0.41+0.00%

UDOCFUnidoc Health Corp.

UDOCFUnidoc Health Corp.$0.07+9.63%

PAXHPreAxia Health Care Payment Systems Inc.

PAXHPreAxia Health Care Payment Systems Inc.$0.22+0.00%

OPGNOpGen, Inc.

OPGNOpGen, Inc.$23.91+64.36%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.76-0.29%

NOKNokia

NOKNokia$9.73-0.05%

INTCIntel

INTCIntel$100.23-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.56-0.08%

SMCISuper Micro Computer

SMCISuper Micro Computer$31.20+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$66.30-0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$118.24+0.03%

Questions About EMOR

What is the current price of Healixa?

Healixa is trading at $0.04 per share.

What is the 52-week range for Healixa?

Over the past 52 weeks, Healixa has traded between $0.01 and $0.07.

How much debt does Healixa have?

As of the most recent reporting period, Healixa reported total debt of $6.69M.

How much cash does Healixa have on hand?

Healixa reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Healixa’s dividend yield?

Healixa does not currently have a dividend yield.

Healixa(OTC) EMOR

Healixa Financials at a Glance

EMOR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Healixa

EMOR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Healixa Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EMOR

What is the current price of Healixa?

What is the 52-week range for Healixa?

How much debt does Healixa have?

How much cash does Healixa have on hand?

What is Healixa’s dividend yield?

Premium Investing Services